ALN-VSP

Alnylam Inks Oncology Deal - Analyst Blog
NASDAQ
Sun, 07/15/12 - 12:11 pm
Alnylam
Ascletis Pharmaceuticals
ALN-VSP
Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire
Sun, 06/5/11 - 10:04 am
Alnylam
liver cancer
ALN-VSP
RNAi